China National Accord Medicines Corporation Ltd. (SHE:000028)
China
· Delayed Price · Currency is CNY 25.21
+0.06 (0.24%)
May 23, 2025, 2:45 PM CST
SHE:000028 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 72,879 | 73,675 | 74,844 | 72,701 | 67,648 | 59,130 | Upgrade
|
| Other Revenue | 703 | 703 | 633.35 | 742.57 | 710.01 | 519.9 | Upgrade
|
| Revenue | 73,582 | 74,378 | 75,477 | 73,443 | 68,358 | 59,649 | Upgrade
|
| Revenue Growth (YoY) | -3.03% | -1.46% | 2.77% | 7.44% | 14.60% | 13.00% | Upgrade
|
| Cost of Revenue | 65,565 | 66,180 | 66,471 | 64,561 | 60,372 | 52,623 | Upgrade
|
| Gross Profit | 8,017 | 8,198 | 9,006 | 8,883 | 7,986 | 7,026 | Upgrade
|
| Selling, General & Admin | 6,284 | 6,407 | 6,404 | 6,374 | 5,772 | 4,925 | Upgrade
|
| Research & Development | 24.22 | 24.55 | 26.82 | 9.07 | - | - | Upgrade
|
| Other Operating Expenses | 169.88 | 158.44 | 93.73 | 180.1 | 139.09 | 141.8 | Upgrade
|
| Operating Expenses | 6,595 | 6,684 | 6,596 | 6,585 | 5,955 | 5,088 | Upgrade
|
| Operating Income | 1,422 | 1,514 | 2,411 | 2,298 | 2,031 | 1,938 | Upgrade
|
| Interest Expense | -247.18 | -258.3 | -248.38 | -261.91 | -288.04 | -258.19 | Upgrade
|
| Interest & Investment Income | 273.16 | 300.32 | 314.58 | 212.07 | 366.68 | 420.41 | Upgrade
|
| Currency Exchange Gain (Loss) | -1.85 | -1.85 | 2.95 | -0.44 | 0.41 | -0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -22.34 | -15.44 | -27.9 | -1.89 | -4.87 | -0.61 | Upgrade
|
| EBT Excluding Unusual Items | 1,424 | 1,539 | 2,452 | 2,245 | 2,105 | 2,100 | Upgrade
|
| Impairment of Goodwill | -887.85 | -887.85 | - | -38.98 | -162.69 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -22.81 | -22.81 | -15.16 | 28.87 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 9.86 | 11.87 | 45.31 | 8.31 | 4.25 | 6.79 | Upgrade
|
| Asset Writedown | -83.98 | -84 | -0.64 | -18.87 | -75.55 | -1.31 | Upgrade
|
| Legal Settlements | -0.51 | -0.51 | -3.25 | -0.05 | -0.55 | -16.51 | Upgrade
|
| Other Unusual Items | 25.32 | 19.81 | -5.12 | 86.36 | 104.09 | 68.43 | Upgrade
|
| Pretax Income | 463.55 | 575.47 | 2,473 | 2,311 | 1,975 | 2,157 | Upgrade
|
| Income Tax Expense | 324.99 | 338.47 | 514.74 | 539.33 | 447.21 | 435.94 | Upgrade
|
| Earnings From Continuing Operations | 138.56 | 237 | 1,958 | 1,772 | 1,528 | 1,721 | Upgrade
|
| Minority Interest in Earnings | 443.16 | 405.49 | -359.23 | -285.03 | -191.21 | -319.4 | Upgrade
|
| Net Income | 581.72 | 642.49 | 1,599 | 1,487 | 1,336 | 1,402 | Upgrade
|
| Net Income to Common | 581.72 | 642.49 | 1,599 | 1,487 | 1,336 | 1,402 | Upgrade
|
| Net Income Growth | -64.22% | -59.82% | 7.57% | 11.24% | -4.67% | 10.56% | Upgrade
|
| Shares Outstanding (Basic) | 557 | 557 | 557 | 557 | 557 | 557 | Upgrade
|
| Shares Outstanding (Diluted) | 557 | 557 | 557 | 557 | 557 | 557 | Upgrade
|
| Shares Change (YoY) | -0.01% | -0.12% | 0.12% | - | - | - | Upgrade
|
| EPS (Basic) | 1.04 | 1.15 | 2.87 | 2.67 | 2.40 | 2.52 | Upgrade
|
| EPS (Diluted) | 1.04 | 1.15 | 2.87 | 2.67 | 2.40 | 2.52 | Upgrade
|
| EPS Growth | -64.37% | -59.93% | 7.49% | 11.25% | -4.59% | 10.47% | Upgrade
|
| Free Cash Flow | 1,813 | 2,989 | 2,615 | 2,238 | 1,285 | 1,209 | Upgrade
|
| Free Cash Flow Per Share | 3.26 | 5.37 | 4.69 | 4.02 | 2.31 | 2.17 | Upgrade
|
| Dividend Per Share | 0.366 | 0.366 | 0.680 | 0.615 | 0.462 | 0.615 | Upgrade
|
| Dividend Growth | -46.18% | -46.18% | 10.50% | 33.35% | -25.01% | 33.35% | Upgrade
|
| Gross Margin | 10.90% | 11.02% | 11.93% | 12.09% | 11.68% | 11.78% | Upgrade
|
| Operating Margin | 1.93% | 2.04% | 3.19% | 3.13% | 2.97% | 3.25% | Upgrade
|
| Profit Margin | 0.79% | 0.86% | 2.12% | 2.02% | 1.96% | 2.35% | Upgrade
|
| Free Cash Flow Margin | 2.46% | 4.02% | 3.46% | 3.05% | 1.88% | 2.03% | Upgrade
|
| EBITDA | 1,344 | 1,737 | 3,836 | 2,542 | 2,239 | 2,106 | Upgrade
|
| EBITDA Margin | 1.83% | 2.34% | 5.08% | 3.46% | 3.28% | 3.53% | Upgrade
|
| D&A For EBITDA | -77.69 | 222.98 | 1,426 | 244.32 | 207.45 | 167.71 | Upgrade
|
| EBIT | 1,422 | 1,514 | 2,411 | 2,298 | 2,031 | 1,938 | Upgrade
|
| EBIT Margin | 1.93% | 2.04% | 3.19% | 3.13% | 2.97% | 3.25% | Upgrade
|
| Effective Tax Rate | 70.11% | 58.82% | 20.81% | 23.34% | 22.64% | 20.21% | Upgrade
|
| Revenue as Reported | 73,582 | 74,378 | 75,477 | - | - | - | Upgrade
|
| Advertising Expenses | - | - | - | 46.67 | 44.12 | - | Upgrade
|
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.